1. E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis
    Zhifeng Ma et al, 2023, Current Molecular Pharmacology CrossRef
  2. The Role of MicroRNAs in Hepatoblastoma Tumors
    Ion Cristóbal et al, 2019, Cancers CrossRef
  3. Integration of TE Induces Cancer Specific Alternative Splicing Events
    Woo Ryung Kim et al, 2022, International Journal of Molecular Sciences CrossRef
  4. A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
    Devis Pascut et al, 2019, Scientific Reports CrossRef
  5. DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma
    Bin Zhu et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
  6. Molecular mechanism for metformin to enhance pro-apoptotic effect of sorafenib in HepG2 cells
    Yan-Qing Ye et al, 2020, World Chinese Journal of Digestology CrossRef
  7. MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
    Lisa Kinget et al, 2021, Cancers CrossRef
  8. Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
    Tomasz M. Grzywa et al, 2020, Cancers CrossRef
  9. MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAs
    Giorgia Castellani et al, 2022, Frontiers in Oncology CrossRef
  10. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
    Behnaz Lahooti et al, 2021, Frontiers in Oncology CrossRef
  11. The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
    Yin-Xiang Ren et al, 2022, Journal of Oncology CrossRef
  12. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
    Mohamed H. Yousef et al, 2020, BioMed Research International CrossRef